Table 1 Characteristics of the subjects
From: Ischemic stroke in young patients in Medellín, Colombia
Characteristic | Descriptive statistic (N = 237) | |
|---|---|---|
Absolute frequency | Relative frequency (%) | |
Obesity | 30 | 12.7 |
Dyslipidemia | 20 | 8.5 |
Smoking | 70 | 29.5 |
Arterial hypertension | 75 | 31.7 |
Diabetes | 19 | 8.1 |
Without Sleep apnea | 234 | 98.7 |
Cancer | 7 | 3.0 |
HIV | 2 | 0.8 |
Syphilis | 3 | 1.3 |
Alcohol intake | 55 | 23.2 |
Marihuana | 21 | 8.9 |
Cocaine | 23 | 9.7 |
Other substances | 8 | 3.4 |
Use of oral contraceptives | 9 | 3.8 |
Postpartum | 2 | 0.8 |
Ischemic cardiac disease | 7 | 3.0 |
Heart failure | 14 | 5.9 |
Peripheral arterial disease | 3 | 1.3 |
Previous ischemic stroke | 30 | 12.6 |
Family history of ischemic stroke | 20 | 8.4 |
Valvular AF | 2 | 0.8 |
Non valvular AF | 1 | 0.4 |
Valve replacement | 12 | 5.0 |
Without PFO | 233 | 98.3 |
Without ASA | 233 | 98.3 |
Low levels of Vitamin B12 | 27 | 11.4 |
Migraine | 22 | 9.2 |
APS | 2 | 0.8 |
SLE | 8 | 3.4 |
Anticardiolipin antibodies | 17 | 7.2 |
Lupus anticoagulant | 18 | 7.6 |
PC deficiency | 3 | 1.3 |
PS deficiency | 7 | 3.0 |
Hyperhomocysteinemia | 4 | 1.7 |
Factor V Leiden | 1 | 0.4 |
Without Prothrombin deficiency | 7 | 3.0 |
Other thrombophilia (AT-III deficiency) | 1 | 0.4 |
Stroke etiology | ||
Craniocervical arterial dissection | 28 | 11.8 |
Large-artery atherosclerosis | 17 | 7.2 |
Small-vessel disease | 16 | 6.8 |
Substance abuse | 11 | 4.6 |
PFO | 11 | 4.6 |
Valve replacement | 11 | 4.6 |
Dilated cardiomyopathy (ejection fraction < 35%) | 10 | 4.2 |
Atrial fibrillation | 8 | 3.4 |
Intracardiac thrombi | 6 | 2.5 |
APS | 5 | 2.1 |
Rheumatic cardiac disease | 4 | 1.7 |
Central nervous system primary vasculitis | 3 | 1.3 |
Infectious endocarditis | 3 | 1.3 |
PFO + ASA | 3 | 1.3 |
Moyamoya syndrome | 3 | 1.3 |
Reversible cerebral vasoconstriction syndrome | 3 | 1.3 |
Left ventricle hypokinesis | 2 | 0.8 |
Tuberculous vasculitis | 2 | 0.8 |
Meningovascular syphilis | 2 | 0.8 |
CADASIL | 1 | 0.4 |
Fibromuscular dysplasia | 1 | 0.4 |
Hypercoagulability secondary to HIV | 1 | 0.4 |
Hypercoagulability secondary to nephrotic syndrome (primary glomerulonephritis) | 1 | 0.4 |
Hypercoagulability secondary to nephrotic syndrome (Diabetic nephropathy) | 1 | 0.4 |
Hypoperfusion post cardiac arrest post | 1 | 0.4 |
Acute myocardial infarction | 1 | 0.4 |
Heart failure | 1 | 0.4 |
Irregularity of intracerebral vessels | 1 | 0.4 |
Paraneoplastic hypercoagulability syndrome | 1 | 0.4 |
Thrombophilia (protein S deficiency) | 1 | 0.4 |
Vasculitis | 1 | 0.4 |
Acquired thrombophilia (protein S deficiency, protein C and ATIII) | 1 | 0.4 |
SLE vasculitis | 1 | 0.4 |
Toxic vasculitis secondary to cocaine abuse | 1 | 0.4 |